Laman UtamaPGEN • NASDAQ
add
Precigen Inc
$4.00
Selepas Waktu Dagangan:(1.00%)-0.040
$3.96
Tutup: 17 Okt, 8:00:00 PTG GMT-4 · USD · NASDAQ · Penafian
Tutup sebelumnya
$3.49
Julat hari
$3.39 - $4.05
Julat tahun
$0.65 - $5.23
Permodalan pasaran
1.41B USD
Bilangan Purata
5.77J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | 856.00K | 19.39% |
Perbelanjaan pengendalian | 27.16J | 8.29% |
Pendapatan bersih | -26.64J | 54.68% |
Margin untung bersih | -3.11K | 62.04% |
Pendapatan bagi setiap syer | -0.08 | 23.22% |
EBITDA | -27.23J | -10.23% |
Kadar cukai berkesan | -0.01% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 59.75J | 205.86% |
Jumlah aset | 101.90J | 39.28% |
Jumlah liabiliti | 107.79J | 259.43% |
Jumlah ekuiti | -5.90J | — |
Syer tertunggak | 297.97J | — |
Harga kepada buku | -29.08 | — |
Pulangan pada aset | -60.38% | — |
Pulangan pada modal | -691.86% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -26.64J | 54.68% |
Tunai daripada operasi | -18.98J | 17.87% |
Tunai daripada pelaburan | 28.44J | 90.18% |
Tunai daripada pembiayaan | -1.77J | -3,496.15% |
Perubahan bersih dalam tunai | 7.70J | 194.68% |
Aliran tunai bebas | -15.55J | 23.39% |
Perihal
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
Diasaskan
21 Mei 1998
Tapak web
Pekerja
143
